ReShape Lifesciences\u00ae Granted Key International Patent in Australia for Its Proprietary Diabetes Neuromodulation Technology

  • Vagal Neuromodulation Offers a Novel Approach to Treating Type 2 Diabetes and Hypoglycemia Vagal Neuromodulation Offers a Novel Approach to Treating Type 2 Diabetes and Hypoglycemia